Department of Rehabilitation Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Department of Rehabilitation Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
J Spinal Cord Med. 2024 Jul;47(4):573-583. doi: 10.1080/10790268.2022.2154733. Epub 2023 Mar 29.
To assess COVID-19 vaccination status among individuals with spinal cord injury (SCI).
A cross-sectional study.
Twelve hospitals from all regions of Thailand.
One hundred and eighty people with SCI were randomly selected from the Thai SCI registry database.
Not applicable.
The primary outcome, which was the COVID-19 vaccination status, and the secondary outcomes, which were the number of vaccination doses, satisfaction and dissatisfaction aspects, and barriers to vaccination, were recorded using a specifically developed questionnaire over the telephone during February to March 2022. Data were analyzed using descriptive analyses, bivariate, and multivariable analyses.
Of the 96 people with SCI who were able to respond, the prevalence of receiving at least one dose was 77% but the prevalence of receiving a booster dose was 20%. Being non-traumatic SCI correlated negatively with having received any vaccination doses when compared to traumatic SCI. Most of the participants were satisfied with the government provision of COVID-19 vaccines. The major barriers to vaccination were problems related to a negative attitude toward the vaccination, followed by transportation difficulties and wheelchair-inaccessible vaccination sites.
Seventy-seven percent of people with SCI participating in this study received at least one dose of the COVID-19 vaccine, whereas only 20% of them received a booster dose of the COVID-19 vaccination. To increase the prevalence of vaccination, healthcare providers should deliver the fact regarding COVID-19 vaccination to reduce negative attitudes, as well as remove physical barriers to vaccination places for people with SCI.
评估脊髓损伤(SCI)患者的 COVID-19 疫苗接种状况。
横断面研究。
泰国所有地区的 12 家医院。
从泰国 SCI 登记数据库中随机选择了 180 名 SCI 患者。
不适用。
主要结局指标为 COVID-19 疫苗接种状况,次要结局指标为疫苗接种剂数、满意度和不满度方面、以及接种障碍,这些都是通过专门开发的问卷,于 2022 年 2 月至 3 月期间通过电话进行记录。数据采用描述性分析、双变量和多变量分析进行分析。
在 96 名能够应答的 SCI 患者中,至少接种一剂的患病率为 77%,但接种加强针的患病率为 20%。与创伤性 SCI 相比,非创伤性 SCI 与接种任何疫苗剂量呈负相关。大多数参与者对政府提供的 COVID-19 疫苗感到满意。接种疫苗的主要障碍是与对疫苗接种的负面态度相关的问题,其次是交通困难和轮椅无法进入的接种点。
本研究中,77%的 SCI 患者至少接种了一剂 COVID-19 疫苗,而其中只有 20%的患者接种了 COVID-19 疫苗加强针。为了提高疫苗接种率,医护人员应提供有关 COVID-19 疫苗接种的事实,以减少负面态度,并为 SCI 患者消除接种障碍。